Tags: Monoclonal AntibodiesCancerAntibody ResearchBispecific AntibodiesDLBCL Trials
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | ||
| 2 | Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA | ||
| 3 | Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. | ||
| 4 | Meghana Keshavan STAT News Biotech nerd and writer @statnews. | ||
| 5 | Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California | ||
| 6 | Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts | ||
| 7 | Ryan Haumschild, PharmD, MS, MBA Pharmacy Times Director of Pharmacy. Editorial Board member. Atlanta, Georgia | Current Landscape of Bispecific Therapies for RRMM - 3 months ago | |
| 8 | Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
| 9 | John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. | Novel Anti-IgG Drug Hits Mark in Sjogren's Patients - 3 months ago | |
| 10 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA |